CD69 Is the Crucial Regulator of Intestinal Inflammation: A New Target Molecule for IBD Treatment?
Joint Authors
Radulovic, Katarina
Niess, Jan Hendrik
Source
Journal of Immunology Research
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-02-22
Country of Publication
Egypt
No. of Pages
12
Main Subjects
Abstract EN
CD69 has been identified as an early activation marker of lymphocytes.
However, recent work has indicated that CD69 plays an essential role for the regulation of inflammatory processes.
Particularly, CD69 is highly expressed by lymphocytes at mucosal sites being constantly exposed to the intestinal microflora (one of the nature’s most complex and most densely populated microbial habitats) and food antigens, while only a small number of circulating leukocytes express this molecule.
In this review we will discuss the role of CD69 in mucosal tissue and consider CD69 as a potential target for the development of novel treatments of intestinal inflammation.
American Psychological Association (APA)
Radulovic, Katarina& Niess, Jan Hendrik. 2015. CD69 Is the Crucial Regulator of Intestinal Inflammation: A New Target Molecule for IBD Treatment?. Journal of Immunology Research،Vol. 2015, no. 2015, pp.1-12.
https://search.emarefa.net/detail/BIM-1068496
Modern Language Association (MLA)
Radulovic, Katarina& Niess, Jan Hendrik. CD69 Is the Crucial Regulator of Intestinal Inflammation: A New Target Molecule for IBD Treatment?. Journal of Immunology Research No. 2015 (2015), pp.1-12.
https://search.emarefa.net/detail/BIM-1068496
American Medical Association (AMA)
Radulovic, Katarina& Niess, Jan Hendrik. CD69 Is the Crucial Regulator of Intestinal Inflammation: A New Target Molecule for IBD Treatment?. Journal of Immunology Research. 2015. Vol. 2015, no. 2015, pp.1-12.
https://search.emarefa.net/detail/BIM-1068496
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1068496
